Search research articles
Contact Us
Filters
Showing results (31-40 of 84) with videos related to
Page
of 9
Sort By:
Biomedicines
|
June 24, 2022
C-Reactive Protein and Serum Albumin Ratio: A Feasible Prognostic Marker in Hospitalized Patients with COVID-19
Vicente Giner-Galvañ, Francisco José Pomares-Gómez, José Antonio Quesada, et al.
The Journal of Rheumatology
|
February 17, 2019
Longterm Efficacy and Safety of Monotherapy versus Combination Therapy in Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Retrospective RESCLE Registry Study
Melani Pestaña-Fernández, Manuel Rubio-Rivas, Carles Tolosa-Vilella, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
May 3, 2021
Anti-Polymyositis/Scl Antibodies in Systemic Sclerosis: Clinical Associations in a Multicentric Spanish Cohort and Review of the Literature
Nerea Iniesta Arandia, Gerard Espinosa, Alfredo Guillén Del Castillo, et al.
Plos One
|
January 21, 2022
Use of glucocorticoids megadoses in SARS-CoV-2 infection in a spanish registry: SEMI-COVID-19
Cristina Lavilla Olleros, Cristina Ausín García, Alejandro David Bendala Estrada, et al.
Scientific Reports
|
July 3, 2021
Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients
Antonio Ramos-Martínez, Lina Marcela Parra-Ramírez, Ignacio Morrás, et al.
Seminars in Arthritis and Rheumatism
|
June 18, 2016
Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry
Carles Tolosa-Vilella, Maria Lluisa Morera-Morales, Carmen Pilar Simeón-Aznar, et al.
Clinical and Experimental Rheumatology
|
October 6, 2017
Clinical and epidemiological differences between men and women with systemic sclerosis: a study in a Spanish systemic sclerosis cohort and literature review
Mayka Freire, Alberto Rivera, Bernardo Sopeña, et al.
Scientific Reports
|
March 29, 2022
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
Alfredo Guillén-Del-Castillo, Manuel López Meseguer, Vicent Fonollosa-Pla, et al.
Internal and Emergency Medicine
|
November 29, 2021
Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry
Francesc Formiga, Manuel Rubio-Rivas, José María Mora-Luján, et al.
Rheumatology (Oxford, England)
|
August 27, 2020
The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i)
Melani Pestaña-Fernández, Manuel Rubio-Rivas, Carles Tolosa-Vilella, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 84) with videos related to
Sort By:
Page
of 9
Biomedicines
|
June 24, 2022
C-Reactive Protein and Serum Albumin Ratio: A Feasible Prognostic Marker in Hospitalized Patients with COVID-19
Vicente Giner-Galvañ, Francisco José Pomares-Gómez, José Antonio Quesada, et al.
The Journal of Rheumatology
|
February 17, 2019
Longterm Efficacy and Safety of Monotherapy versus Combination Therapy in Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Retrospective RESCLE Registry Study
Melani Pestaña-Fernández, Manuel Rubio-Rivas, Carles Tolosa-Vilella, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
May 3, 2021
Anti-Polymyositis/Scl Antibodies in Systemic Sclerosis: Clinical Associations in a Multicentric Spanish Cohort and Review of the Literature
Nerea Iniesta Arandia, Gerard Espinosa, Alfredo Guillén Del Castillo, et al.
Plos One
|
January 21, 2022
Use of glucocorticoids megadoses in SARS-CoV-2 infection in a spanish registry: SEMI-COVID-19
Cristina Lavilla Olleros, Cristina Ausín García, Alejandro David Bendala Estrada, et al.
Scientific Reports
|
July 3, 2021
Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients
Antonio Ramos-Martínez, Lina Marcela Parra-Ramírez, Ignacio Morrás, et al.
Seminars in Arthritis and Rheumatism
|
June 18, 2016
Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry
Carles Tolosa-Vilella, Maria Lluisa Morera-Morales, Carmen Pilar Simeón-Aznar, et al.
Clinical and Experimental Rheumatology
|
October 6, 2017
Clinical and epidemiological differences between men and women with systemic sclerosis: a study in a Spanish systemic sclerosis cohort and literature review
Mayka Freire, Alberto Rivera, Bernardo Sopeña, et al.
Scientific Reports
|
March 29, 2022
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
Alfredo Guillén-Del-Castillo, Manuel López Meseguer, Vicent Fonollosa-Pla, et al.
Internal and Emergency Medicine
|
November 29, 2021
Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry
Francesc Formiga, Manuel Rubio-Rivas, José María Mora-Luján, et al.
Rheumatology (Oxford, England)
|
August 27, 2020
The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i)
Melani Pestaña-Fernández, Manuel Rubio-Rivas, Carles Tolosa-Vilella, et al.
Page
of 9